Jul 16, 2026 09:00AM
Jul 16, 2026 09:00AM
Jul 8, 2026 08:00AM
Jul 8, 2026 08:00AM
Jun 30, 2026 09:17AM
Jun 30, 2026 09:15AM
Jun 29, 2026 07:06PM FDA approves Arcutis' roflumilast cream for plaque psoriasis in children 2+
Jun 29, 2026 07:06PM
May 6, 2026 04:00PM
Apr 27, 2026 08:01AM
Apr 27, 2026 08:00AM
Apr 22, 2026 08:04AM
Apr 22, 2026 08:00AM
Apr 8, 2026 09:15AM The Credibility Filter Wall Street Uses to Sort Biotech Winners
Apr 7, 2026 12:26PM
Apr 7, 2026 07:30AM
Mar 28, 2026 11:00AM
Mar 28, 2026 11:00AM
Mar 18, 2026 08:00AM
Mar 10, 2026 09:00AM
Mar 10, 2026 09:00AM Arcutis Announces Publication of Positive Long-Term Safety and Efficacy Data with ZORYVE® (roflumilast) Cream 0.05% for Treatment of Mild-to-Moderate Atopic Dermatitis in Children Ages 2–5 in Pedi
Mar 5, 2026 09:01AM
Mar 5, 2026 09:00AM
Feb 25, 2026 04:00PM
Feb 24, 2026 09:15AM
Feb 2, 2026 08:00AM
Feb 2, 2026 08:00AM
Jan 12, 2026 08:10AM Arcutis projects ZORYVE sales of $455-470 million for 2026
Jan 12, 2026 08:00AM
Dec 21, 2025 08:00PM
Nov 17, 2025 08:04AM
Nov 17, 2025 08:00AM
Nov 13, 2025 08:00AM
Nov 13, 2025 08:00AM
Nov 4, 2025 08:04AM Arcutis publishes long-term ZORYVE safety data for seborrheic dermatitis
Nov 4, 2025 08:00AM
Oct 30, 2025 09:15AM
Oct 30, 2025 08:03AM
Oct 30, 2025 08:00AM
Oct 28, 2025 08:34AM
Oct 28, 2025 08:30AM
Oct 24, 2025 08:00AM Arcutis presents new ZORYVE data on sleep quality and long-term control
Oct 24, 2025 08:00AM
Oct 6, 2025 08:00AM
Oct 6, 2025 08:00AM
Sep 17, 2025 04:00AM
Sep 16, 2025 09:00AM
Sep 3, 2025 11:44AM
Sep 3, 2025 11:43AM Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% to Expand Indication for Treatment of Plaque Psoriasis in Children Ages 2 to 5
Sep 3, 2025 07:30AM

325,893 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All